Why nano-capitalization public companies should evaluate strategic alternatives, including going private transactions
The Capital Alliance Blog
MARCH 9, 2020
If a $20 million capitalization company spends about $800,000 (4% of its value) in incremental expenses annually to remain a public company, is that a good value for shareholders? It might make sense for a biotech company, for example, that is researching a new drug and needs ready access to capital. Strategic alternatives.
40 
Let's personalize your content